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Objective: ​The aim of this study was to determine whether machine           
learning could reduce the number of examinations the radiologist         
must read by using a machine learning classifier for interpreting          
negative mammograms that it is confident in, and offloading or          
deferring the uncertain predictions to a radiologist for interpretation. 
Methods: ​Mammograms were obtained from a private imaging        
dataset containing over 7,000 patients collected through six NHS         
Breast Screening Program centers throughout the UK. A convolutional         
neural network in conjunction with multi-task learning was used to          
extract imaging features from mammograms that mimic the        
radiological assessment provided by a radiologist, the patient’s        
non-imaging features and pathology outcomes. A deep neural        
network was then used to concatenate and fuse multiple         
mammogram views to predict both a diagnosis and a         
recommendation of whether or not additional radiological assessment        
was needed.  
Results: 10-fold cross-validation was used on 2000 randomly selected          
patients from the dataset; the remainder of the dataset was used for            
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convolutional neural network training. While maintaining an       
admissible NPV of 0.99, the proposed model was able to reduce 34%            
(95% confidence interval, 25-43%) and 91% (95% CI: 88% - 94%) of            
the negative mammograms from the radiologist for test sets with a           
cancer prevalence of 15% and 1%, respectively. 
Conclusion: ​Machine learning was leveraged to successfully reduce the         
number of negative mammography examinations that radiologists       
need to examine without degrading diagnostic accuracy. 
 
Introduction 
The total number of screening mammography examinations       
conducted in the US alone is nearly 40 million annually and increasing            
[1]. Moreover, as examination volumes and time of interpretation         
increase with newer screening technologies such as digital breast         
tomosynthesis (DBT), radiologists will be forced to read more patients          
in less time [2]. Since a large majority of mammograms a radiologist            
examines are negative, machine learning methods that could triage a          
subset of examinations as negative with extremely high accuracy and          
refer the rest to a breast imager could significantly reduce the daily            
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interpretive workload of radiologists, freeing up time to focus on more           
suspicious examinations and diagnostic work-ups.  
Recent advances in artificial intelligence, particularly deep learning,        
have led to significant improvements in computer-aided diagnosis        
(CAD) and decision support [3] but have not yet provided mechanisms           
for effectively reducing the number of examinations that a radiologist          
reads. The most popular CAD-based methods are centered around         
improving detection and diagnostic performance through CAD [4], but         
still require manual examination and validation by an expert         
radiologist. This comes with the overhead of additional CAD software          
interfacing for the radiologist, which has been shown to significantly          
increase the average reading time per patient [5]. 
Unlike related works using convolutional neural networks (CNNS)        
for mammography that attempt to completely automate and replace         
the radiologist [6-12], we depart from these methods by exploring a           
more conservative approach. Specifically, we explore a hybridized        
approach of mammography triage where some mammograms are        
autonomously diagnosed as being negative by a machine learning         
classifier and the remaining exams are read by a radiologist. 
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To address this, we extended and modified the implementation of          
Man and Machine Mammography Oracle (MAMMO) that was        
presented in Kyono et al. [13]. MAMMO was originally developed as a            
clinical decision support system that aimed to reduce the number of           
patients (both positive and negative) the radiologist read by relying on           
the decisions of a machine learning classifier for diagnosing         
mammograms that it was confident in, and offloading or deferring the           
uncertain decisions to a radiologist. However, in this study we          
redesigned MAMMO into a new system (Figure 1), called Autonomous          
Radiologist Assistant (AURA), which aimed to reduce the negative         
patient workload for the radiologist while sustaining a high negative          
predictive value (NPV).  
The purpose of this proof-of-concept study was to determine         
whether the AURA system could autonomously triage patients        
between a machine learning classifier and a radiologist to effectively          
reduce the number of negative mammograms that a radiologist reads          






The ​Tommy ​dataset was originally compiled to determine the         
efficacy and diagnostic performance of DBT in comparison to digital          
mammography and was collected through six NHS Breast Screening         
Program (NHSBSP) centers throughout the UK [14]. It is a rich and            
well-labeled dataset with over 7,000 patients (over a 1,000 malignant)          
who received diagnostic mammograms, and includes radiological       
assessments, density estimates (​µ ​= 38​.​2, ​σ ​= 20​.​7), age at           
examination (​µ ​= 56​.​5, ​σ ​= 8​.​75), and pathology outcomes from core            
biopsy or surgical excision. The ​Tommy ​dataset does not include          
ethnicity or socioeconomic breakdown, and was therefore not        
factored in this study. 
Although not all patients in the ​Tommy ​dataset underwent biopsy          
or had a later follow up examination, each patient underwent expert           
radiologist interpretation of both DBT and mammography modalities        
that significantly reduced the likelihood of false negative readings by          
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as much as 15-30% [14]. Patient distributions for age, breast density,           
and dominant radiological features are shown in Table 1.  
The ​Tommy ​dataset was designed to challenge the radiologist with          
overlapping breast tissue cases. The patient criteria for selection were          
one of the following: 1) women recalled after routine breast screening           
between the ages of 47 and 73, or 2) women with a family history of               
breast cancer attending annual screening between ages of 40 and 49.           
Mammograms were read by over thirty radiologists with at least 2           
years of experience reading 5000 mammograms or more per year. 
 
Multi-task feature extraction 
The ability for CNNs to learn complex spatial relationships and          
learn subtle and intricate pixel-based patterns make them a perfect          
tool for learning from radiological images [15]. The first step involved           
training a CNN using multi-task learning (MTL) to predict both the           
diagnosis and radiological assessments given a single mammogram        
image. Syeda-Mahmood [16] demonstrated the importance of       
incorporating clinical knowledge with medical imaging to improve        
clinical inference. Motivated by this, MTL was used to predict the           
radiological assessments for each mammogram to learn refined        
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feature representations and improve classification performance of the        
primary task, diagnosis, by obligating the CNN to learn the radiological           
assessment known to be associated with cancer. There were five          
other auxiliary tasks, which are shown as the outputs of Step 1 (Figure             
1) and include the mammographic sign (e.g. circumscribed mass,         
spiculated mass, asymmetrical density, etc.), mammographic suspicion       
(similar to BI-RADS), mammographic conspicuity (either not visible,        
barely visible, not clear, or clearly visible), estimated breast density          
from a 10-cm VAS (visual analogue scale), and patient age at reading.            
Both breast density and patient age were included as auxiliary tasks           
because of their known associations with breast cancer [17, 18].          
Training details regarding CNN architecture, hyperparameters, and       
image preprocessing were implemented from Kyono et al. [13]. 
 
Autonomous diagnosis 
The second step of AURA involved autonomous diagnosis of a          
patient by considering all four mammogram views, rather than one          
view as done in Step 1. This was done by training a classifier that takes               
as input the CNN predicted multi-task outputs (MTO) for each of a            
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patient’s mammogram views and their non-imaging features to issue a          
patient-level diagnosis. We chose to combine multiple mammogram        
views by concatenating over the CNN predicted MTO, rather than the           
penultimate dense layers as done by Carnerio et al. and Geras et al.             
[8,19]. This provided a couple noteworthy advantages. First, the MTO          
were extracted imaging features that emulated the radiological        
assessment and are what the radiologist would naturally consider         
when reading multiple mammogram views, such as asymmetries in         
breast density between left and right mammogram views [20].         
Second, by pre-training our CNN in the first training phase, the MTO            
served as a refined feature space for combining mammogram views          
that improves performance in limited data scenarios commonly        
encountered in the medical imaging domain. 
 
Autonomous assessment 
The objective of Step 3 was to determine whether the diagnostic           
prediction made in Step 2 could be trusted, while also considering the            
patient’s non-imaging features, such as age, and the radiological         
predictions of the CNN from Step 1. The primary design goal of AURA             
was to reduce the number of negative mammograms the radiologist          
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interprets by offloading examinations to a machine learning classifier         
(Step 2) while preserving a desirable NPV (greater than 99%). It is            
important to note that the NPV of AURA is representative over the            
collaborative system comprised of AURA autonomously diagnosing       
some partition of the cases and the radiologist diagnosing the rest. A            
loss function presented in Kyono et al. [13] was used to satisfy this             
constrained optimization that takes into consideration the       
performance of the radiologist. The uncertainty of decisions was         
calculated using dropout and test-time augmentation [21, 22].        
Dropout was performed at a rate of 0.4 per dense layer and test-time             
augmentation was performed at 50 random samples per patient. 
 
Validation of Performance 
To evaluate the performance of AURA for ​patient triage​,         
experiments were conducted on the ​Tommy ​dataset. 10-fold        
cross-validation was performed on 2000 randomly selected patients        
from the ​Tommy ​dataset and the remainder was used for CNN           
training. Specifically, the dataset was split into 10 even groups (folds),           
with each model tested on one fold, validated on another, and trained            
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on the remaining folds. This was repeated 10 times over each unique            
test set to provide a more stable and bias free model estimate. In             
deep learning, a validation set is used for determining model fitness           
and to find a stopping point for model training, while a test set is              
reserved for evaluating model performance.  
To ensure the 2,000 patient subset was a proportional subset of           
the entire dataset, we maintained the dataset’s 15% malignancy rate          
through the test set as well, by randomly sampling 300 malignant           
patients and 1700 normal patients from the entire dataset. Each of           
the cross-validation folds maintained the same 15% cancer prevalence         
as well.  
To demonstrate the impact of cancer prevalence on the outcome          
of patient triage by AURA, AURA was applied on reduced cancer           
prevalence subsets, where cancer patients were randomly removed        
from each cross-validation test set to obtain the desired prevalence,          
specifically 1% and 5%.  
Models were saved and evaluated at the point with the highest           
area under the receiver operating characteristic curve (AUROC). The         
performance of AURA ​patient triage ​was evaluated by investigating         
the number of patients that AURA deferred to the radiologist while           
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still satisfying an admissible NPV (greater than 99%). Additionally, to          
better understand the patient distributions that AURA successfully        
diagnosed, an evaluation of patient triage by attributes, such as breast           
density or age, was investigated. The odds ratio for each patient           
demographic examined was calculated using logistic regression       





For mammograms to autonomously bypass radiologist viewing,       
AURA must perform at some minimum NPV. In clinical practice, a           
desirable NPV is greater than 99%. Figure 2 shows various desired           
NPV operating points with the respective maximum number of         
patients that AURA was able to filter from the radiologist while           
maintaining the desired NPV (​x​-axis) for three stratifications of cancer          
prevalence (15%, 5%, and 1%). It is important to note that the            
reported NPV of the AURA system is comprised of both the AURA            
machine learning classifier and a radiologist.  
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At a cancer prevalence of 15%, AURA is expected to correctly           
diagnose approximately 34% (95% CI: 25% - 43%) of the patients while            
maintaining a NPV of at least 99%. The number of patients AURA            
filters are significantly improved when considering a cancer        
prevalence closer to screening distributions such as the 1% prevalence          
(Figure 2), where nearly 91% (95% CI: 88% - 94%) of the patients are              
screened from the radiologist. In summary, the data in Figure 2 shows            
that the number of patients that AURA filters is increased by either            
lowering the NPV threshold or by a decrease in cancer prevalence.           
Since the NPV threshold is likely not to change, this suggests that            
AURA should be favored in populations with lower cancer prevalence,          
i.e., screening populations. 
AURA had a higher odds ratio of negative classification and NPV for            
patients that had attributes associated with lower likelihoods (or         
suspicion) of cancer, i.e., patients with lower breast density, patients          
with low visual conspicuity in their mammograms (suspicious regions         
are not clearly defined), patients with no suspicious imaging features          
in their mammograms, patients recalled by assessment (rather than         
family history), and younger patients (Table 2).  
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Similar to the odds ratio and NPV results, when investigating the           
patient populations that AURA filtered (and was confident in         
diagnosing) from the radiologist (Table 2), it was discovered to          
correlate with the same attributes associated with lower likelihoods of          
cancer, except for breast density. AURA chose to autonomously         
diagnose a higher percentage of patients with breast densities in the           
25% to 50% range. This is justified by a lower cancer prevalence and a              
higher demographic of these cases existing in the dataset population          
(Table 1). The latter would result in more samples available for           
training and improving the AURA classifier. 
 
Discussion 
In this work, we showed the potential for improving the radiologist           
workflow using machine learning that is currently not explored in the           
current literature and practice. We presented the AURA system on a           
private mammography dataset and demonstrated that the AURA        
system could autonomously triage patients between a machine        
learning classifier and a radiologist to effectively reduce the number of           
negative mammograms that a radiologist reads while maintaining an         
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admissible NPV (above 99%). It was discovered that AURA filtered          
patients from the radiologist with attributes known to be associated          
with lower likelihoods of cancer, such as younger age, lower breast           
density, etc. (Table 2). 
As far as we know, this is the first study investigating machine            
learning methods for reducing the number of negative mammograms         
a radiologist needs to read without replacing the radiologist entirely.          
In terms of neural network architecture, the closest work to ours is            
the prior study by Kooi and Karssemeijer [9], which investigated the           
impact of dataset and image size on predicting BI-RADS. 
AURA may provide several benefits for radiologists. First, we found          
that AURA was capable of significantly decreasing the workload for          
the radiologist by 34% (95% CI: 25-43%), in a diagnostic setting (15%            
cancer prevalence) and by nearly 91% (95% CI: 88% - 94%) for a             
screening-like setting (1% prevalence). Although the ​Tommy ​dataset is         
comprised of diagnostic mammography and a direct comparison        
cannot be drawn to screening mammography directly, the 1% cancer          
prevalence results show significant promise for applications to        
screening mammography. Second, AURA filters the patients with        
lower likelihoods of cancer from the radiologist, leaving them with          
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more time to focus on the difficult cases that AURA is uncertain about.             
This additional time will allow for better scrutinization of the difficult           
cases, and may reduce the likelihood of misdiagnoses [23]. Lastly,          
AURA provides a palatable solution for incorporating artificial        
intelligence into radiology that does not completely remove the         
clinician from a radiological workflow and strives to do so for only            
particular examinations. 
The current study has several limitations. First, AURA experiments         
were conducted on a mammography dataset originally collected for a          
reader study comparing DBT and digital mammography performance        
and is comprised of a high concentration of patients with overlapping           
breast tissue. Because of this, it is expected that AURA performance           
would improve significantly if performed on a screening population.         
Second, AURA would have benefited from increased image quantity         
and size (for CNN training), which has been demonstrated by Kooi and            
Karssemeijer [9] to improve classification performance in deep        
learning for mammography.  
Lastly, our dataset did not contain annotated regions of interest          
(ROI), and was therefore not leveraged in AURA’s training regime and           
architecture. ROI-based machine learning methods have been shown        
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to improve performance on mammograms on several small datasets         
[6-12, 24-30], and would be expected to improve classification         
performance of AURA as well.  
In addition to validation on larger, population-based imaging        
datasets, future research directions include investigating AURA’s       
potential for patient triage based on differing levels of suspicion for           
cancer. Such a triage system would allow examinations that are most           
likely to have cancer to be interpreted earlier by the radiologist and            
expedite faster recall and diagnostic evaluation [31]. Similarly,        
patients with a higher likelihood of cancer could be seen earlier in the             
day when the radiologist is more alert, thus mitigating misdiagnoses          
associated with fatigue [23]. Lastly, due to the visual similarity          
between DBT images and mammograms, AURA can easily be extended          
and tested on DBT.  
In conclusion, our study demonstrates a proof-of-concept for        
machine learning to be used for improving breast imaging workflow          
for mammogram interpretation. AURA opens the door for realistic         
synergistic relationships between radiologist and machine with       
benefits that surpass those reported in the existing literature, and          
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provides methods for artificial intelligence integration that can be         
integrated into clinical practice in the near term. 
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Fig 1. AURA system level illustration. In Step 1, all four of a patient’s              
mammograms were passed to a multi-task feature extractor, i.e., a          
convolutional neural network (CNN) trained using multi-task learning        
(MTL) to emulate the mammographic predictions of a radiologist. In          
Step 2, the MTL predictions extracted from the individual         
mammograms were fused by a deep neural network to provide a           
multi-view diagnosis on the basis of both a patient’s imaging and           
non-imaging features. Lastly, AURA considered the radiological       
predicted features (CNN multi-task outputs from Step 1), the         
multi-view cancer prediction (from Step 2), and the patient’s         
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non-imaging features to issue a recommendation for ​patient triage ​to          
determine which patients could be autonomously diagnosed. 
 
 
Fig 2.  Percentage of patients that AURA filters from the radiologist 
across various NPV thresholds, as well as various cancer prevalence 





Table 1: ​Tommy ​dataset patient distributions for breast density, age,          
mammographic signs, and mammographic conspicuity. 
 
Attribute Value Benign Malignant Prevalence 
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0%- 25% 1789 454 20.24% 
25%- 50% 2942 554 15.85% 
50%- 75% 1075 231 17.69% 
75%- 100% 358 60 14.35% 
Age 
Under 50 
years 625 51 7.54% 
50-60 years 3963 571 12.59% 
Over 60 
years 1576 677 30.05% 
Mammograp
hic Signs 
No sign of 
cancer 2688 76 2.75% 
Circumscribe
d mass 1469 119 7.49% 
Spiculated 
mass 62 434 87.50% 
Microcalcific
ation 859 319 27.08% 
Distortion 144 145 50.17% 
Assymetrical 




None visible 2036 61 2.91% 
Barely visible 255 59 18.79% 
Visible, but 
not clear 1097 288 20.79% 
Clearly 
visible 2037 871 29.95% 
Case Type 
Assessment 4920 1201 19.62% 
Family 
History 1382 98 6.62% 
 
 
Table 2: AURA Performance at the highest (15%) cancer prevalence.          
The odds ratio of receiving a negative diagnosis was calculated using           
logistic regression analysis. The AURA NPV was calculated as the joint           
NPV of the radiologist and the AURA classifier, where the average           
percentage filtered represents the number of patients that the AURA          
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classifier autonomously diagnosed (the rest received a diagnosis from         
a radiologist).  Each value is shown with a 95% confidence interval. 
 




































































Spic. mass 0.64 ±  0.05 
34.29% ± 
9.04 
3.80%  ± 
2.04 


















































Assessment 0.94 ±  0.02 
48.23% ± 
6.37 
25.20% ± 
4.12 
Family 
History 
138.30 ± 
33.31 
99.42% ± 
0.03 
39.94% ± 
11.70 
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